| ||||||||||||||||||||||||||||||||||||
2012-10-25
[DIV28_ANNOUNCEMENT] Shiffman, Sullivan to Keynote 28/50 Addiction Conference
[DIV28SUPER] NIDA Neuroscience Update October 25, 2012
I. Requests of $500,000 or more for direct costs in any year for an NIH grant application
II. NIH needs your help!
III. Looking for Scientific Resources? Use the Neuroscience Information Framework (NIF)!
IV. 3rd Generation Rat shRNA library Resource Now Available
V. The ENCODE/Roadmap epigenomics tutorial
VI. Travel awards to attend the 75th Annual Scientific Meeting of the College of Problems on Drug Dependence (CPDD)
VII. Highlighted Funding Opportunity Announcements
TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
The National Institute on Drug Abuse (NIDA) at the National Institutes of Health is an agency of the United States Department of Health and Human Services
------------------------
I. Requests of $500,000 or more for direct costs in any year for an NIH grant application
Applicants requesting $500,000 or more in direct costs in any year (excluding consortium F&A) must contact NIH program staff at least 6 weeks before submitting the application and follow the Policy on the Acceptance for Review of Unsolicited Applications that Request $500,000 or More in Direct Costs as described in the SF 424 (R&R) Application Guide. Thus, applicants submitting for the February 5, 2013 deadline must obtain permission no later than December 23, 2012.
II. NIH needs your help!
NIH is seeking community input on a priority list for renewable affinity reagents for human transcription factors. For more information or to provide input, please click HERE.
This outreach effort is part of the Protein Capture Reagents Program. This program was initiated by the NIH Common Fund in response to concerns raised by scientific community regarding the lack of access to well-characterized, analytically validated and affordable renewable protein capture reagents. This is a pilot program that aims to evaluate if a community resource of high quality, renewable affinity reagents can be economically generated and validated for all human proteins, and to develop technologies that will lead to next generation platforms for producing renewable protein capture reagents. This pilot effort includes the generation of affinity reagents (monoclonal antibodies and recombinant Fabs) against all human transcription factors as a test case.
III. Looking for Scientific Resources? Use the Neuroscience Information Framework (NIF)!
Find what you are looking for at NIF. The Neuroscience Information Framework (NIF) provides easy access to the largest collection of neuroscience information on the web. Whether you need data, tools, papers, materials, services, webinars, blogs or funding opportunities, NIF's semantic search can help. See how NIF can enhance your research by visiting http://neuinfo.org. NIF has just released a brand new interface to make it easier to search and browse our contents (over 150 databases).
This resource is supported by the NIH and is freely available to researchers and the public.
IV. 3rd Generation Rat shRNA library Resource Now Available
The NIH Blueprint, NCI and NHGRI are pleased to support the development of a Rat shRNA library by the Hannon Laboratory at Cold Sping Harbor Laboratory for the research community. For more information and to order see http://rat3.cancan.cshl.edu/
V. The ENCODE/Roadmap epigenomics tutorial
The Roadmap Epigenomics and ENCODE projects are hosting a tutorial on using these resources to understand the role of genetic variation in human disease and human biology. The tutorial will be on 8 November in San Francisco, as a satellite meeting of the 2012 ASHG annual meeting. This free tutorial is open to all. It is not required to register for the ASHG meeting to attend our tutorial. Topics to be covered include what data are available, how the data can be displayed and downloaded, how they can be used in genetic research on human disease, and how they have been used. To register for this free tutorial, to download materials for the tutorial, or to learn more about ENCODE and Roadmap Epigenomics, please visit our web site:
VI. Travel awards to attend the 75th Annual Scientific Meeting of the College of Problems on Drug Dependence (CPDD)
The Women and Sex/Gender Differences Program at the National Institute on Drug Abuse (NIDA) is soliciting applications for a limited number of travel awards to attend the 75th Annual Scientific Meeting of the College of Problems on Drug Dependence (CPDD) to be held in San Diego, California, June 15-20, 2013 (http://www.cpdd.vcu.edu/ ). Deadline for applications is December 3, 2012.
If you have any questions about this award, please contact Dr. Samia Noursi, snoursi@mail.nih.gov; 301-594-5622
VII. Highlighted Funding Opportunity Announcements
| Related | |||||||
| NIDA | 08/24/2012 | 10/19/2012 | 11/20/2012 | R01 | The Interplay of Substance Abuse and HIV-1 Infection on Glial Cell Function (R01) | ||
| NIDA | 08/24/2012 | 10/19/2012 | 11/20/2012 | R21 | The Interplay of Substance Abuse and HIV-1 Infection on Glial Cell Function (R21) | ||
| NIDA | 06/13/2012 | 07/09/2012 | 08/10/2013 | R01, R03, R15, R21, R21/R33, R37, U01 | Establish Sharing of Human Brain Image Data Relevant to Drug Addiction (Admin Supp) | ||
| NIDA | 06/08/2012 | 08/14/2012 | 08/22/2014 | R25 | Research Education Grants for Statistical and Computational Training in the Genetics of Addiction (R25) | ||
| NIH | 08/23/2012 | 10/01/2012 | 01/17/2015 | R21 | Tobacco Control Regulatory Research - R21 | ||
| NIH | 08/23/2012 | 10/01/2012 | 01/17/2015 | R01 | Tobacco Control Regulatory Research - R01 | ||
| NIH | 08/23/2012 | 10/01/2012 | 01/17/2015 | R03 | Tobacco Control Regulatory Research - R03 | ||
| Roadmap | 08/07/2012 | 10/19/2012 | 11/22/2012 | R01 | Development and Application of Systems Approaches for Analyzing the Impact of Genomic Variation on Tissue Transcriptomes (R01) | ||
| NIEHS | 08/23/2012 | 10/19/2012 | 11/20/2012 | R01 | TaRGET I: Chromatin Structure, Genomics, and Transcriptional Responses to the Environment (R01) | ||
| NIDA | 11/16/2010 | 01/05/2011 | 01/08/2014 | R01 | Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R01) | ||
| NIDA | 11/16/2010 | 01/16/2011 | 01/08/2014 | R21 | Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R21) | ||
| NIDA | 11/16/2010 | 01/16/2011 | 01/08/2014 | R03 | Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R03) | ||
| NIDA | 11/10/2010 | 01/05/2011 | 01/08/2014 | R01 | The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) | ||
| NIDA | 11/09/2010 | 01/05/2011 | 01/08/2014 | R01 | Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) |
| NIDA | 04/03/2012 | National Institute on Drug Abuse (NIDA) Seeks Applications Using the JAX Diversity Outcross (DO) Mice |
2012-10-24
[DIV28SUPER] NIDA junior investigator travel award for 2013 CPDD
The Women and Sex/Gender Differences Program at the National Institute on Drug Abuse (NIDA) is soliciting applications for a limited number of travel awards to attend the 75th Annual Scientific Meeting of the College of Problems on Drug Dependence (CPDD) to be held in San Diego, California, June 15-20, 2013 (http://www.cpdd.vcu.edu/ ). An applicant's CPDD abstract on women or sex/gender differences must be accepted for presentation by CPDD for either an oral session, a poster session, or a symposium. The preferred candidate for this award is a researcher who demonstrates commitment to research on women and sex/gender differences in any area of drug abuse, both human and animal. Applicants must fall into one of the following categories: graduate and/or medical student, post-doctoral student, medical resident, and investigator with no more than five years past the doctoral degree or residency. In addition, an applicant must be first author on their CPDD oral or poster abstract. Minority investigators and male investigators are especially encouraged to apply. Federal employees are ineligible.
Application procedures:
First, follow the CPDD abstract submission instructions (http://www.cpdd.vcu.edu/) . Next, submit your travel award application materials to Dr. Samia Noursi at snoursi@nida.nih.gov in the following format and with the required attachments:
· E-mail subject line: 2013 NIDA Women & Sex/Gender Junior Investigator Travel Award Application
· Attach a copy of the abstract that you submitted to CPDD, including title and authors. Or, if applicable, attach the accepted symposium submission.
· Attach your curriculum vitae. List all NIH grant support if applicable.
· Attach a cover letter stating (1) your eligibility, (2) your interest in continuing to pursue research on women or sex/gender differences, and (3) your career goals. Please include your mailing address, telephone number and e-mail address in your cover letter.
Deadline for applications is December 3, 2012.
If you have any questions about this award, please contact Dr. Samia Noursi, snoursi@mail.nih.gov; 301-594-5622
Cora Lee Wetherington, Ph.D.
Women & Sex/Gender Differences Research Coordinator
National Institute on Drug Abuse
6001 Executive Blvd., Suite 4282, MSC 9555
Bethesda, MD 20892-9555 (For overnight mail: Rockville, MD 20852)
Phone: (301) 435-1319
Fax: (301) 594-6043
E-mail: cwetheri@nida.nih.gov
2012-10-19
[DIV28SUPER] RFI Analysis of Input into the Scientific Strategic Plan for National Institute on Substance Use and Addiction Disorders
Dear Colleagues,
I'm sending you this email to keep you apprised of new information concerning the pending reorganization of substance use, abuse and addiction research at the National Institutes of Health (NIH). Earlier this year, many of you submitted comments in response to an NIH Request for Information (RFI) on this topic. An analysis of those comments is now complete, and has been posted on the NIH feedback webpage: http://feedback.nih.gov/index.php/suaa/rfi-analysis/.
Ripple Effect Communications, Inc. was contracted by NIH to provide this third party analysis and report of the comments received through the RFI. The report provides an analysis of the 500 submissions received in response to the RFI. The report can be viewed and downloaded at http://www.nih.gov/blog/feedback/substance-abuse/RFI_101012.pdf
PLEASE NOTE: This is NOT the draft strategic plan nor the draft portfolio integration plan that you are also expecting to see from NIH. Those draft plans are still in development and we expect that NIH will release them for public review and comment sometime in November. We will update you as soon as we learn more about these pending issues expected next month. Thank you for your attention to and interest in this process.
Best regards,
David Shurtleff
David Shurtleff, Ph.D.
Acting Deputy Director
National Institute on Drug Abuse
6001 Executive Boulevard Rm 5274, MSC 9581 Bethesda, MD 20892-9581
E-mail: dshurtle@mail.nih.gov
Tel: 301-443-6480
Fax: 301-443-9127
2012-10-11
[DIV28SUPER] Free naloxone for opioid overdose webinar available
Webinar: Naloxone for Opioid Overdose
"Take-Home Naloxone for Opioid Overdose: Exploring the Legal, Policy and Practice Landscapes"
Thursday, October 18, 2012
1 p.m., ET
Fatal drug overdose has increased more than six-fold in the past three decades, and now claims the lives of more than 36,000 Americans every year. Many of these deaths are caused by opioids. Opioid overdose is typically reversible through the timely administration of the drug naloxone. In this webinar, presenters will provide an overview of the history of overdose education and take-home-naloxone distribution programs. The current state of the medical, legal and policy environments that affect these programs will be discussed as well as options for expanding overdose knowledge and take-home-naloxone access in the future.
Register today for this free event!http://aslme.org/webinar-take-home-naloxone-for-opioid-overdose-exploring-the-legal-policy-and-practice-landscapes?utm_source=October+11%2C+2012+Newsletter&utm_campaign=Newsletter&utm_medium=email
--
Kelly Dunn, Ph.D.
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
WARNING: E-mail sent over the Internet is not secure. Information sent by e-mail may not remain confidential.
DISCLAIMER: This e-mail is intended only for the individual to whom it is addressed. It may be used only in accordance with applicable laws. If you received this e-mail by mistake, notify the sender and destroy the e-mail
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network
2012-10-01
[DIV28SUPER] Frontiers in Addiction Research Mini-convention Sponsored by the National Institute on Drug Abuse, Friday October 12, 2012, Sheraton New Orleans Hotel, New Orleans, LA
Frontiers in Addiction Research Mini-convention
Sponsored by the National Institute on Drug Abuse
Friday, October 12, 2012
Sheraton New Orleans Hotel, 500 Canal Street, New Orleans, LA
Seating is limited. Additional information and registration can be found at: https://seiservices.com/nida/frontiers2012/
The NIDA mini-convention, Frontiers in Addiction Research, held in conjunction with the annual Society for Neuroscience Meeting, will feature outstanding scientists who will present their cutting-edge research on the neurobiology of drug abuse and addiction. The NIDA mini-convention features four symposia, the SfN Jacob P. Waletzky Memorial Lecture and a poster session for early career investigators. The agenda this year includes:
8:00 am- 8:15 am Welcome: NIDA Director
8:15 am- 9:35 am Ghrelin, Leptin and Insulin Modulates Reward
9:35 am-10:10 am Jacob P. Waletzky Memorial Lecture
10:35 am-12:15 pm Role of Phagocytes in Synaptic Plasticity & Remodeling in the Nervous System
12:15 pm- 2:15 pm Early Career Investigators Poster Session
2:15 pm- 3:35 pm Brain Energetics and Neurotransmission: Fueling Neurons and Glia
3:50 pm-5:25 pm Central Nervous System Immune Signaling and Addiction
NIDA will also hold several other events at the Society for Neuroscience meeting, including:
1) Toni S. Shippenberg Memorial Symposium – Friday, October 12, 2012, 6:00-7:30 p.m.
2) Julius Axelrod Lecture and Poster Session – Sunday, October 14, 2012, 6:30-9:00 p.m.
3) NIDA/INSERM Workshop on US-France Collaboration on Drug Abuse and Addiction Research – Monday, October, 15, 2012, 6:30-9:00 p.m.
4) NIH Grant Workshop for Early Career Investigators – Tuesday, October 16, 2012, 6:30-9:00 p.m.
Information on these events can also be found at: https://seiservices.com/nida/frontiers2012/
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to
listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if
successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309